Patients with deletion of the IFN gene cluster show higher mortality in 9 out of 24 cancer types including the brain, breast, cervical, kidney, liver, lung, mesenchyme, mesothelioma, thyroid, and uterus. This evidence concerns the gene IFNA1 and cancer.